Beijing Beizhuo Medical Technology Development Co., Ltd. has successfully secured nearly 100 million yuan in Pre-A round financing, co-led by Yuanming Capital and Zhongguancun Capital, with participation from industrial investors such as Guangzhou Sairuibo Medical Technology Co., Ltd. Multidimensional Capital and Yixin Capital served as financial advisors. The funds will be utilized for upgrading core technologies, advancing clinical projects, obtaining medical device registrations, and expanding into overseas markets, thereby driving the commercialization of China's original non-invasive brain-computer technology. Beizhuo Medical specializes in non-invasive brain-computer interaction and neural modulation, pioneering the NeuroSpace×AI neural spatial intelligence model.
